The prognostic value of tumour–stroma ratio in primary breast cancer with special attention to triple-negative tumours: a review

por Kramer, C. J. H., Vangangelt, K. M. H., van Pelt, G. W., Dekker, T. J. A., Tollenaar, R. A. E. M., Mesker, W. E.
Publicado 2018

Are disseminated tumor cells in bone marrow and tumor-stroma ratio clinically applicable for patients undergoing surgical resection of primary colorectal cancer? The Leiden MRD stu...

por Vogelaar, F. J., van Pelt, G. W., van Leeuwen, A. M., Willems, J. M., Tollenaar, R. A. E. M., Liefers, G. J., Mesker, W. E.
Publicado 2016

Comment on: The prognostic significance of tumour-stroma ratio in oestrogen receptor-positive breast cancer

por Mesker, W E, Dekker, T J A, de Kruijf, E M, Engels, C C, van Pelt, G W, Smit, V T H B M, Tollenaar, R A E M
Publicado 2015

Scoring the tumor-stroma ratio in colon cancer: procedure and recommendations

por van Pelt, G. W., Kjær-Frifeldt, S., van Krieken, J. H. J. M., Al Dieri, R., Morreau, H., Tollenaar, R. A. E. M., Sørensen, F. B., Mesker, W. E.
Publicado 2018

Outcomes following pancreatic surgery using three different thromboprophylaxis regimens

por Hanna‐Sawires, R. G., Groen, J. V., Klok, F. A., Tollenaar, R. A. E. M., Mesker, W. E., Swijnenburg, R. J., Vahrmeijer, A. L., Bonsing, B. A., Mieog, J. S. D.
Publicado 2019

Prognostic value of tumor–stroma ratio combined with the immune status of tumors in invasive breast carcinoma

por Vangangelt, K. M. H., van Pelt, G. W., Engels, C. C., Putter, H., Liefers, G. J., Smit, V. T. H. B. M., Tollenaar, R. A. E. M., Kuppen, P. J. K., Mesker, W. E.
Publicado 2017

The value of tumor-stroma ratio as predictor of pathologic response after neoadjuvant chemoradiotherapy in esophageal cancer

por van Pelt, G.W., Krol, J.A., Lips, I.M., Peters, F.P., van Klaveren, D., Boonstra, J.J., de Steur, W.O., Tollenaar, R.A.E.M., Farina Sarasqueta, A., Mesker, W.E., Slingerland, M.
Publicado 2019

Quality assessment of estrogen receptor and progesterone receptor testing in breast cancer using a tissue microarray-based approach

por Dekker, T. J. A., ter Borg, S., Hooijer, G. K. J., Meijer, S. L., Wesseling, J., Boers, J. E., Schuuring, E., Bart, J., van Gorp, J., Bult, P., Riemersma, S. A., van Deurzen, C. H. M., Sleddens, H. F. B. M., Mesker, W. E., Kroep, J. R., Smit, V. T. H. B. M., van de Vijver, M. J.
Publicado 2015

Erratum to: Quality assessment of estrogen receptor and progesterone receptor testing in breast cancer using a tissue microarray-based approach

por Dekker, T. J. A., ter Borg, S., Hooijer, G. K. J., Meijer, S. L., Wesseling, J., Boers, J. E., Schuuring, E., Bart, J., van Gorp, J., Bult, P., Riemersma, S. A., van Deurzen, C. H. M., Sleddens, H. F. B. M., Mesker, W. E., Kroep, J. R., Smit, V. T. H. B. M., van de Vijver, M. J.
Publicado 2015